BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lahad A, Weiss B. Current therapy of pediatric Crohn’s disease. World J Gastrointest Pathophysiol 2015; 6(2): 33-42 [PMID: 25977836 DOI: 10.4291/wjgp.v6.i2.33]
URL: https://www.wjgnet.com/2150-5330/full/v6/i2/33.htm
Number Citing Articles
1
David A. Hill, William A. Faubion. Pediatric Inflammatory Bowel Disease2017; : 15 doi: 10.1007/978-3-319-49215-5_2
2
Olga Bellou, Dimosthenis Chrysikos, Ourania Schoinohoriti, Ioannis Alexandrou, Efstratios Christianakis. Perianal Skin Tags Revealing Asymptomatic Crohn’s Disease in a 12-Year-Old Child With Growth Impairment: A Case ReportCureus 2023;  doi: 10.7759/cureus.37513
3
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, Valentina Silvera, Giulia Rendo, Lucia Cococcioni, Dario Dilillo, Valeria Calcaterra, Gian Vincenzo Zuccotti. Dual biological therapy and small molecules in pediatric inflammatory bowel diseasePharmacological Research 2023; 196: 106935 doi: 10.1016/j.phrs.2023.106935
4
Kelly Barnhill, Kelly Barnhill, Alan Gutierrez, Alan Gutierrez, Amy Potts, Amy Potts, Morgan Devlin, Wendy Richardson, Laura Hewitson, Ayse Yesim Gocmen. Implementation of an Elemental Diet in Five Children Diagnosed with Autism Spectrum Disorder Presenting with Gastrointestinal Disease: A Brief ReportInternational Journal of Nutrition 2020; 5(2): 1 doi: 10.14302/issn.2379-7835.ijn-20-3181
5
Steven Levitte, Reza Yarani, Abantika Ganguly, Lynne Martin, John Gubatan, Helen R. Nadel, Benjamin Franc, Roberto Gugig, Ali Syed, Alka Goyal, K. T. Park, Avnesh S. Thakor. Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional ProgramJournal of Clinical Medicine 2023; 12(6): 2386 doi: 10.3390/jcm12062386
6
Yichen Wang, Chun-Wei Pan, Yuting Huang, Xin Zheng, Si Li, Mingyue He, Jana G Hashash, Francis A Farraye, Adam C Ehrlich. Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019Inflammatory Bowel Diseases 2024;  doi: 10.1093/ibd/izae093
7
Changhee Ha, Eun Sil Kim, Yiyoung Kwon, Yon Ho Choe, Mi Jin Kim, Soo-Youn Lee. <p>The Identification of a Novel Thiopurine S-Methyltransferase Allele, <em>TPMT*45</em>, in Korean Patient with Crohn’s Disease</p>Pharmacogenomics and Personalized Medicine 2020; : 665 doi: 10.2147/PGPM.S279446
8
Toshio Arai, Fernando Lopes, Adam Shute, Arthur Wang, Derek M. McKay. Young mice expel the tapeworm Hymenolepis diminuta and are protected from colitis by triggering a memory response with worm antigenAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(4): G461 doi: 10.1152/ajpgi.00295.2017
9
Sunghyun An, Homin Huh, Jae Sung Ko, Jin Soo Moon, Ky Young Cho. Establishment and Characterization of Patient-Derived Intestinal Organoids from Pediatric Crohn’s Disease PatientsPediatric Gastroenterology, Hepatology & Nutrition 2024; 27(6): 355 doi: 10.5223/pghn.2024.27.6.355
10
Ha-Yeon Song, Woo Sik Kim, Jin-Man Kim, Dong-Ho Bak, Jeong Moo Han, Seung-Taik Lim, Eui-Baek Byun. A hydroxyethyl derivative of chrysin exhibits anti-inflammatory activity in dendritic cells and protective effects against dextran sodium salt-induced colitis in miceInternational Immunopharmacology 2019; 77: 105958 doi: 10.1016/j.intimp.2019.105958
11
Juan Cristóbal Gana, Andrea Sepúlveda, Esther Orlanski-Meyer, Luis A Villarroel del Pino, Maria Jose de la Piedra Bustamante, Maria Teresa Olivares Labbe. Tumour necrosis factor-alpha antagonists for treatment of paediatric Crohn’s diseaseCochrane Database of Systematic Reviews 2022; 2022(5) doi: 10.1002/14651858.CD014497
12
Elizabeth A. Jensen, Jonathan A. Young, Samuel C. Mathes, Edward O. List, Ronan K. Carroll, Jaycie Kuhn, Maria Onusko, John J. Kopchick, Erin R. Murphy, Darlene E. Berryman. Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinologyGrowth Hormone & IGF Research 2020; : 101333 doi: 10.1016/j.ghir.2020.101333
13
Amy Johnston, Sabrina Natarajan, Meghan Hayes, Erika MacDonald, Risa Shorr. Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocolBMJ Open 2018; 8(1): e019909 doi: 10.1136/bmjopen-2017-019909
14
Teresa Whited, Albrey Berber. A 17-Year-Old Male With Abdominal Pain in Primary CareThe Journal for Nurse Practitioners 2019; 15(10): e201 doi: 10.1016/j.nurpra.2019.04.012
15
Alexander Oberc, Brian K. Coombes. Convergence of External Crohn’s Disease Risk Factors on Intestinal BacteriaFrontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00558
16
Yamini Sharma, Athos Bousvaros, Enju Liu, Julia Bender Stern. Natural history of children with mild Crohn’s diseaseWorld Journal of Gastroenterology 2019; 25(30): 4235-4245 doi: 10.3748/wjg.v25.i30.4235
17
Sana Syed, Asad Ali, Christopher Duggan. Environmental Enteric Dysfunction in ChildrenJournal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 6 doi: 10.1097/MPG.0000000000001147
18
Elizabeth A. Jensen, Jonathan A. Young, Jaycie Kuhn, Maria Onusko, Joshua Busken, Edward O. List, John J. Kopchick, Darlene E. Berryman. Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent mannersPituitary 2022; 25(1): 116 doi: 10.1007/s11102-021-01179-8
19
Franziska Roth-Walter, Sonja Berger, Nicole Luckschander-Zeller. Comparative Medicine2017; : 47 doi: 10.1007/978-3-319-47007-8_4
20
Leo Fawaz, Yousif Slim, Peter N. Freswick. Endoscopic Guided Dilations without Intralesional Corticosteroid Injections: Pediatric Crohn’s Patients Case SeriesReports 2024; 7(4): 81 doi: 10.3390/reports7040081
21
Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel DiseasesNutrients 2023; 15(15): 3377 doi: 10.3390/nu15153377
22
Linah Wetthasinghe, Hien Fuh Ng, Kee Seang Chew, Way Seah Lee. Effect of exclusive enteral nutrition on gut microbiota in Malaysian children with Crohn’s diseaseIOP Conference Series: Earth and Environmental Science 2024; 1408(1): 012003 doi: 10.1088/1755-1315/1408/1/012003
23
Csaba Orbán, Dolóresz Szabó, Anna Bajnok, Barna Vásárhelyi, Tivadar Tulassay, András Arató, Gábor Veres, Gergely Toldi. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patternsOncotarget 2016; 7(29): 44966 doi: 10.18632/oncotarget.10036
24
Dhiren Patel, Shailender Madani, Shraddha Patel, Lokesh Guglani. Review of pulmonary adverse effects of infliximab therapy in Crohn’s diseaseExpert Opinion on Drug Safety 2016; 15(6): 769 doi: 10.1517/14740338.2016.1160053
25
Leena Amine, Ibtihal S Abdelgadir, Karen Neves, Mamoun Elawad, Amel Hassan, Anthony K Akobeng. Tacrolimus for induction therapy in active Crohn's diseaseCochrane Database of Systematic Reviews 2018;  doi: 10.1002/14651858.CD013142
26
Mackenzie L Lauro, Jason M Burch, Catherine Leimkuhler Grimes. The effect of NOD2 on the microbiota in Crohn's diseaseCurrent Opinion in Biotechnology 2016; 40: 97 doi: 10.1016/j.copbio.2016.02.028